FCH
RVMD icon

Freestone Capital Holdings’s Revolution Medicines RVMD Stock Holding History

Freestone Capital Holdings’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$395K Hold
2,109
– – 0.01% 438
2026
Q1 		$205K Buy
+2,109
New +$213K 0.01% 516

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Freestone Capital Holdings's RVMD Position: Q2 2026 in Review

Freestone Capital Holdings held its Revolution Medicines (RVMD) position steady in Q2 2026 at 2,109 shares worth $395K. The position accounts for 0.01% of the portfolio, ranked #438.

Freestone Capital Holdings first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Freestone Capital Holdings held 2,109 shares of Revolution Medicines worth $395K as of Q2 2026.
  • Freestone Capital Holdings left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up 0.01% of Freestone Capital Holdings's portfolio in Q2 2026, its #438 holding.
  • Freestone Capital Holdings first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.